Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
Arteriosclerosis, Thrombosis, and Vascular Biology|August 13, 2011
Inhibition of nitric oxide-stimulated vasorelaxation by carbon monoxide-releasing moleculesAntonia Marazioti, Mariarosaria Bucci, Ciro Coletta, et al.
World Journal of Urology|November 13, 2012
PDE5 inhibition against acute renal ischemia reperfusion injury in rats: does vardenafil offer protection?Iason Kyriazis, George C Kagadis, Panagiotis Kallidonis, et al.
Cardiovascular Research|March 8, 2019
Investigating and re-evaluating the role of glycogen synthase kinase 3 beta kinase as a molecular target for cardioprotection by using novel pharmacological inhibitorsPanagiota-Efstathia Nikolaou, Kerstin Boengler, Panagiotis Efentakis, et al.
British Journal of Pharmacology|May 1, 2021
Involvement of 3',5'-cyclic inosine monophosphate in cystathionine γ-lyase-dependent regulation of the vascular toneEmma Mitidieri, Valentina Vellecco, Vincenzo Brancaleone, et al.
Pharmacological Research|August 14, 2016
Screening of a composite library of clinically used drugs and well-characterized pharmacological compounds for cystathionine β-synthase inhibition identifies benserazide as a drug potentially suitable for repurposing for the experimental therapy of colon cancerNadiya Druzhyna, Bartosz Szczesny, Gabor Olah, et al.
Cardiovascular Research|June 23, 2019
Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropyPanagiotis Efentakis, Aimilia Varela, Evangelia Chavdoula, et al.
British Journal of Pharmacology|March 2, 2026
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in reviewAndreas Papapetropoulos, Stavros Topouzis, Steve P H Alexander, et al.
British Journal of Pharmacology|March 23, 2024
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in reviewAndreas Papapetropoulos, Stavros Topouzis, Steve P H Alexander, et al.
British Journal of Pharmacology|August 11, 2024
Natural product pharmacology: the British Journal of Pharmacology perspectiveXin Wang, Angelo A Izzo, Andreas Papapetropoulos, et al.
British Journal of Pharmacology|February 19, 2025
Novel drugs approved by the EMA, the FDA and the MHRA in 2024: A year in reviewStavros Topouzis, Andreas Papapetropoulos, Steve P H Alexander, et al.
Pageof 17